Figures & data
Figure 1 Cohort enrolment and follow-up among patients initiating first-line ART in South Africa Pre-UTT vs during UTT.
![Figure 1 Cohort enrolment and follow-up among patients initiating first-line ART in South Africa Pre-UTT vs during UTT.](/cms/asset/f880f58e-1128-4d42-8c25-72d78379d9b5/dtcr_a_12180911_f0001_c.jpg)
Table 1 Demographic and Clinical Characteristics at Treatment Initiation Among Patients Initiating ART in South Africa Pre-UTT vs During UTT
Table 2 Treatment Outcomes at 12 Months on Treatment Among Patients Initiating ART in South Africa Pre-UTT vs During UTT
Table 3 Unadjusted and Adjusted Estimates of the Relation Between Pre-UTT Initiation and UTT Initiation on LTFU
Table 4 Unadjusted and Adjusted Estimates of the Relation Between Pre-UTT Initiation and UTT Initiation on LTFU Among Patients Initiating Treatment with a CD4 Cell Count ≤500 Copies/mm3
Figure 3 Kaplan-Meier survival estimates of lost to follow-up among patients initiating ART in South Africa Pre-UTT vs during UTT (n=2410).
![Figure 3 Kaplan-Meier survival estimates of lost to follow-up among patients initiating ART in South Africa Pre-UTT vs during UTT (n=2410).](/cms/asset/44a6f199-71cb-4b8f-ab69-f327fddae731/dtcr_a_12180911_f0003_c.jpg)
Table 5 Unadjusted and Adjusted Estimates of the Relation Between Pre-UTT Initiation and UTT Initiation on Virologic Suppression at 12 Months (VL≤400 Copies/mL)